zileuton has been researched along with Brain Inflammation in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abood, M; Chu, J; Giannopoulos, PF; Kirby, LG; Li, JG; Praticò, D; Sperow, M; Yu, WH | 1 |
Barcelos, Lda S; de Miranda, AS; de Oliveira, AC; Machado, FS; Moraes, MF; Parreiras, PM; Rachid, MA; Resende, GH; Rodrigues, FG; Silva, BC; Silveira, AL; Teixeira, AL; Teixeira, MM | 1 |
Chen, CM; Jin, CD; Shi, SS; Tu, XK; Wang, CH; Wen, S; Yang, WZ; Yang, YK; Zhang, YL | 1 |
3 other study(ies) available for zileuton and Brain Inflammation
Article | Year |
---|---|
Pharmacologic inhibition of 5-lipoxygenase improves memory, rescues synaptic dysfunction, and ameliorates tau pathology in a transgenic model of tauopathy.
Topics: Animals; Arachidonate 5-Lipoxygenase; Brain; Cerebellum; Cerebral Cortex; Cyclin-Dependent Kinase 5; Disease Models, Animal; Encephalitis; Excitatory Postsynaptic Potentials; Humans; Hydroxyurea; Lipoxygenase Inhibitors; Memory; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neurons; Phenotype; Phosphorylation; Synapses; tau Proteins; Tauopathies | 2015 |
The 5-lipoxygenase (5-LOX) Inhibitor Zileuton Reduces Inflammation and Infarct Size with Improvement in Neurological Outcome Following Cerebral Ischemia.
Topics: Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain Infarction; Carotid Stenosis; Cytokines; Disease Models, Animal; Down-Regulation; Encephalitis; Enzyme-Linked Immunosorbent Assay; Hydroxyurea; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred C57BL; Nervous System Diseases | 2015 |
Zileuton reduces inflammatory reaction and brain damage following permanent cerebral ischemia in rats.
Topics: Animals; Anti-Inflammatory Agents; Blotting, Western; Brain; Brain Ischemia; Cerebral Infarction; Disease Models, Animal; Encephalitis; Enzyme-Linked Immunosorbent Assay; Hydroxyurea; Immunohistochemistry; Interleukin-1beta; Lipid Peroxidation; Lipoxygenase Inhibitors; Male; Malondialdehyde; Neuroprotective Agents; Neutrophil Infiltration; Nitric Oxide; Nitric Oxide Synthase Type II; Peroxidase; Rats; Rats, Sprague-Dawley; Time Factors; Transcription Factor RelA; Tumor Necrosis Factor-alpha | 2010 |